GLP-1 drugs like Ozempic can raise bone and tendon injury risk, study suggests

GLP-1 drugs like Ozempic can raise bone and tendon injury risk, study suggests

The miracle of rapid weight loss has always come with fine print. Until recently, it read mostly like a list of digestive complaints - stomachaches, constipation - generally unpleasant but tolerable and rarely severe. New research presented this month suggests the drugs may affect something more structural: bone.